What You Should Know:
- Verily and Lumea today announced a strategic partnership to develop products that can diagnose, prognose, and guide prostate cancer therapy selection with improved objectivity and efficiency.
- Lumea’s integrated digital pathology solution will validate Verily’s AI method for improving cancer detection and grading in partnership with Google Health.
Partnership Goals
The Verily-Lumea collaboration will utilize Lumea’s digital pathology platform
Read More
Healthcare Algorithms | News, Analysis, Insights - HIT Consultant
Precision Medicine Startup Prenosis Raises $20M for Acute Care Solutions, Starting with Sepsis
What You Should Know:
- Prenosis, Inc., a precision medicine company, announced a venture investment from PACE Healthcare Capital, an early-stage investment firm committed to improving health outcomes. This investment brings total funding in the company to over $20 million, including partnerships with Foxconn, Roche Diagnostics, the Defense Threat Reduction Agency, and others.
- Precision medicine company will use the funding to
Read More
BrightInsight & UCB Partner to Build Digital Care Solutions for Rare Diseases
What You Should Know:
- BrightInsight, provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced a partnership with global biopharma, UC to build digital care solutions for rare diseases.
- BrightInsight will build and bring to market a digital disease management solution to support patients with Myasthenia Gravis (MG), a rare autoimmune disease that disrupts how nerves communicate with muscles, affecting more than 700,000 people
Read More
How Health Systems Can Use AI to Optimize Resources and Maximize Patient Satisfaction
Over the past several years, nearly all of the leading health systems in the United States have adopted some form of AI, such as machine learning (ML) or natural language processing (NLP), to assist in managing healthcare operations. The unprecedented growth and development of AI has been instrumental in transforming health system administration, healthcare data analytics and patient diagnosis and treatment.
Despite this growth, health systems have yet to maximize the potential of AI to
Read More
Cedars-Sinai Establishes New Division: Artificial Intelligence in Medicine (AIM)
What You Should Know:
- Today, the department of Cedars-Sinai announced it has established a new division to explore how artificial intelligence (AI) can be applied to help solve complex medical problems and enhance clinical care.
- The new division, Artificial Intelligence in Medicine, or AIM will be led by Sumeet Chugh, MD, an associate director of the Smidt Heart Institute and a prominent expert in sudden cardiac arrest, who has long relied on technology and population-wide data to help
Read More
Sirona Medical Acquires Nines Radiology AI Division
What You Should Know:
- Sirona Medical, a software company with a cloud-native solution for radiologists, has announced its acquisition of Nines Radiology’s AI division. Sirona Medical did not acquire Nines' teleradiology business, Nines Radiology. The terms of the deal were not disclosed.
- This is Sirona’s first acquisition just months after its exit from stealth in Aug. 2021 with a total of $62.5M in Series A & B financing rounds.
Why It Matters
The FDA-cleared medical
Read More
7 Burning Questions from Life Sciences Companies on Using AI Agents
Each day life science companies respond to numerous medical information inquires – many of which are similar in nature or can be simply addressed. However, as we have seen in the news reports with the Great Resignation and many workers searching for new careers, the number of individuals interested in working in a medical information contact center may be waning. When you combine this with the rising volume of inquiries or medical inquiries and patient expectations for a real-time response to
Read More
We Recall Drugs with Adverse Effects, So Why Not Recall AI Algorithms with Racial Bias?
Over the last decade, AI has transformed from a futuristic, hype-driven tool, to now being a daily part of our lives. We use AI for everything from unlocking our smartphones, to evaluating our credit scores, to helping clinicians make patient care decisions. In particular, the potential of AI to transform drug development and patient care is unparalleled – its ability to gather objective insights can help elevate a clinical trial’s data and bring potentially life-saving drugs to people in need
Read More
Cardiologs Awarded FDA Clearance for Pediatric Use of Algorithm
What You Should Know:
Cardiologs announced today that the FDA has cleared their algorithm to be used for the pediatric population - younger than 18. Their technology can now analyze ECG readings for atrial arrhythmias across all age groups.
Cardiologs, a medical technology company committed to transforming cardiac diagnostics using medical-grade artificial intelligence and cloud technology, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)
Read More
Sentara Healthcare Taps Sensyne to Deploy Clinical Algorithms for CKD & CHF
What You Should Know:
- Sentara Healthcare, a health system in NC and VA, just partnered with Sensyne Health to drive clinical research with ethical AI.
- As part of a collaboration agreement, Sentara also becomes the first of several U.S. health systems that will partner with Sensyne to implement new clinical algorithms to support patients with CKD and CHF. The agreement will enable the ethical application of clinical AI research by Sensyne through analyzing Sentara’s patient dataset to
Read More